Skip to search formSkip to main contentSkip to account menu

setastine

Known as: 1-(2-((p-chloromethylphenylbenzyl)oxy)ethyl)hexahydro-1H-azepine, setastinum 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Azepines

Narrower (1)

Loderix

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Assessing the sedative (adverse) effects of antiallergic drugs by quantitative electroencephalography: effects of setastine a non-sedating antihistaminic drug.
In order to assess the effects of Loderix (setastine) on the EEG ten healthy male volunteers were investigated in double-blind… 
1993
1993
Comparative clinical examination of Loderix (setastinum) and astemizole in pollenosis.
The action and side-effects of Loderix (EGIS) were examined in comparison with Hismanal (Janssen) containing the non-sedative H1… 
1991
1991
Loderix (setastine) tablets in the treatment of allergic rhinoconjunctivitis.
The effect of a 3-week treatment with Loderix is examined in an open study in 40 patients suffering from allergic… 
1990
1990
Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
Setastine HCl (N-(1-phenyl-1-[4-chlorophenyl])-etoxy-ethylene-perhydroazepine hydrochloride, Loderix; CAS 64294-95-7) is a potent… 
1987
1987
Comparative two-phase clinicopharmacological trial of a new antihistaminic, EGYT-2062, setastine.
During the two-phase clinicopharmacological trial in humans of a new antihistaminic compound EGYT-2062, setastine developed by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)